ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,356Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 1269

$601K Total Retail Price of All Prescriptions

Rank: 93 out of 1269

432 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 10,162 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 440 377 1 1
LEVOTHYROXINE SODIUM 386 366 2 4
FUROSEMIDE 294 281 3 5
AMLODIPINE BESYLATE 228 221 4 2
WARFARIN SODIUM 221 216 5 12
ATORVASTATIN CALCIUM 212 195 6 7
SIMVASTATIN 200 184 7 3
METOPROLOL TARTRATE 199 186 8 6
CITALOPRAM HBR 198 195 9 21
OMEPRAZOLE 197 148 10 8
IPRATROPIUM-ALBUTEROL 191 191 11 86
METFORMIN HCL 179 140 12 9
MIRTAZAPINE 170 161 13 24
CLOPIDOGREL 160 151 14 32
DONEPEZIL HCL 158 158 15 22
PRAVASTATIN SODIUM 157 148 16 11
GABAPENTIN 157 138 16 17
TRAZODONE HCL 156 142 18 36
PREDNISONE 136 136 19 45
RANITIDINE HCL 136 107 19 27
CRESTOR 135 101 21 25
METOPROLOL SUCCINATE 134 130 22 13
NAMENDA 128 128 23 38
POLYETHYLENE GLYCOL 3350 125 109 24 50
SERTRALINE HCL 117 116 25 23
QUETIAPINE FUMARATE 115 114 26 53
MELOXICAM 111 109 27 68
PLAVIX 109 103 28 47
PANTOPRAZOLE SODIUM 104 100 29 18
TAMSULOSIN HCL 97 81 30 31
TRAMADOL HCL 97 89 30 16
ALLOPURINOL 96 88 32 49
CARVEDILOL 95 87 33 29
OXYCONTIN 93 62 S2 34 116
PAROXETINE HCL 87 75 35 71
POTASSIUM CHLORIDE 82 78 36 26
LOVASTATIN 80 73 37 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 70 38 84
OXYCODONE HCL 76 34 S2 39 34
ADVAIR DISKUS 72 62 40 46
KLOR-CON M20 71 70 41 60
ZOLPIDEM TARTRATE 68 41 42 19
OXYCODONE-ACETAMINOPHEN 68 55 S2 42 44
NYSTATIN 63 62 44 119
DIGOXIN 62 62 45 62
SEROQUEL 62 61 45 104
ALENDRONATE SODIUM 61 61 47 28
CYMBALTA 61 61 47 70
CEFUROXIME 60 57 49 171
CARBIDOPA-LEVODOPA 58 58 50 78
OXYBUTYNIN CHLORIDE ER 57 55 51 130
LOSARTAN POTASSIUM 57 57 51 15
BYSTOLIC 57 57 51 126
FLUOXETINE HCL 56 36 54 83
DIOVAN 55 49 55 35
NEXIUM 54 41 56 41
LYRICA 53 53 57 92
CELEBREX 53 53 57 95
BUPROPION XL 52 42 59 239
OLANZAPINE 51 51 60 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.